0 Évaluations

ID

14518

Description

Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids; ODM derived from: https://clinicaltrials.gov/show/NCT00691873

Lien

https://clinicaltrials.gov/show/NCT00691873

Mots-clés

  1. 19/04/2016 19/04/2016 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

19 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Asthma NCT00691873

    Eligibility Asthma NCT00691873

    1. StudyEvent: Eligibility
      1. Eligibility Asthma NCT00691873
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693 (Inclusion)
    clinical diagnosis and history of moderate persistent allergic asthma
    Description

    moderate persistent allergic asthma

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C4039651 (Moderate persistent allergic asthma)
    SNOMED
    10676391000119108
    body weight >/= 20kg and </= 150kg
    Description

    body weight

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0005910 (Body Weight)
    SNOMED
    27113001
    total serum ige >/= 30 and </= 700iu/ml
    Description

    serum ige

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2229760 (serum IgE measurement)
    on a stable asthma treatment including corticosteroids for the preceding 4 weeks
    Description

    asthma treatment

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0004096 (Asthma)
    SNOMED
    195967001
    LOINC
    MTHU020815
    UMLS CUI [1,2]
    C0040808 (Treatment Protocols)
    UMLS CUI [1,3]
    C0205360 (Stable status)
    SNOMED
    58158008
    LOINC
    LP73394-6
    UMLS CUI [2]
    C0038317 (Steroids)
    SNOMED
    768759001
    LOINC
    LP20784-2
    non smoker for at least 1 year prior to visit 1
    Description

    non smoker

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0337672 (Non-smoker)
    SNOMED
    8392000
    UMLS CUI [1,2]
    C0040223 (Time)
    SNOMED
    410670007
    LOINC
    LP73517-2
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251 (Exclusion Criteria)
    patients with severe asthma
    Description

    severe asthma

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0581126 (Severe asthma)
    SNOMED
    370221004
    history of immunotherapy to any allergen within the past 3 years
    Description

    immunotherapy

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021083 (Immunotherapy)
    SNOMED
    76334006
    UMLS CUI [2]
    C0040223 (Time)
    SNOMED
    410670007
    LOINC
    LP73517-2
    history of anaphylactic allergic reaction
    Description

    anaphylactic reaction

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0002792 (anaphylaxis)
    SNOMED
    39579001
    upper respiratory tract infection
    Description

    upper respiratory tract infection

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0041912 (Upper Respiratory Infections)
    SNOMED
    54150009

    Similar models

    Eligibility Asthma NCT00691873

    1. StudyEvent: Eligibility
      1. Eligibility Asthma NCT00691873
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    moderate persistent allergic asthma
    Item
    clinical diagnosis and history of moderate persistent allergic asthma
    boolean
    C4039651 (UMLS CUI [1])
    body weight
    Item
    body weight >/= 20kg and </= 150kg
    boolean
    C0005910 (UMLS CUI [1])
    serum ige
    Item
    total serum ige >/= 30 and </= 700iu/ml
    boolean
    C2229760 (UMLS CUI [1])
    asthma treatment
    Item
    on a stable asthma treatment including corticosteroids for the preceding 4 weeks
    boolean
    C0004096 (UMLS CUI [1,1])
    C0040808 (UMLS CUI [1,2])
    C0205360 (UMLS CUI [1,3])
    C0038317 (UMLS CUI [2])
    non smoker
    Item
    non smoker for at least 1 year prior to visit 1
    boolean
    C0337672 (UMLS CUI [1,1])
    C0040223 (UMLS CUI [1,2])
    Item Group
    C0680251 (UMLS CUI)
    severe asthma
    Item
    patients with severe asthma
    boolean
    C0581126 (UMLS CUI [1])
    immunotherapy
    Item
    history of immunotherapy to any allergen within the past 3 years
    boolean
    C0021083 (UMLS CUI [1])
    C0040223 (UMLS CUI [2])
    anaphylactic reaction
    Item
    history of anaphylactic allergic reaction
    boolean
    C0002792 (UMLS CUI [1])
    upper respiratory tract infection
    Item
    upper respiratory tract infection
    boolean
    C0041912 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial